195 related articles for article (PubMed ID: 21426259)
1. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity.
Wright GP; Ehrenstein MR; Stauss HJ
Expert Rev Clin Immunol; 2011 Mar; 7(2):213-25. PubMed ID: 21426259
[TBL] [Abstract][Full Text] [Related]
2. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
3. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities.
Brusko TM; Putnam AL; Bluestone JA
Immunol Rev; 2008 Jun; 223():371-90. PubMed ID: 18613848
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T-regulatory cells: toward therapy for human diseases.
Allan SE; Broady R; Gregori S; Himmel ME; Locke N; Roncarolo MG; Bacchetta R; Levings MK
Immunol Rev; 2008 Jun; 223():391-421. PubMed ID: 18613849
[TBL] [Abstract][Full Text] [Related]
5. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
[TBL] [Abstract][Full Text] [Related]
6. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
Selck C; Dominguez-Villar M
Front Immunol; 2021; 12():661875. PubMed ID: 34054826
[TBL] [Abstract][Full Text] [Related]
7. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.
Wright GP; Notley CA; Xue SA; Bendle GM; Holler A; Schumacher TN; Ehrenstein MR; Stauss HJ
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19078-83. PubMed ID: 19884493
[TBL] [Abstract][Full Text] [Related]
8. The role of FOXP3
Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy With Regulatory T Cells: A Beneficial Alliance.
Biswas M; Kumar SRP; Terhorst C; Herzog RW
Front Immunol; 2018; 9():554. PubMed ID: 29616042
[TBL] [Abstract][Full Text] [Related]
10. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
11. Oral tolerance.
Weiner HL; da Cunha AP; Quintana F; Wu H
Immunol Rev; 2011 May; 241(1):241-59. PubMed ID: 21488901
[TBL] [Abstract][Full Text] [Related]
12. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
Janssens I; Cools N
Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
[TBL] [Abstract][Full Text] [Related]
13. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
14. Antigen-based therapies targeting the expansion of regulatory T cells in autoimmune and allergic disease.
Leech M; Anderton S
Chem Immunol Allergy; 2008; 94():201-210. PubMed ID: 18802349
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis.
van Herwijnen MJ; Wieten L; van der Zee R; van Kooten PJ; Wagenaar-Hilbers JP; Hoek A; den Braber I; Anderton SM; Singh M; Meiring HD; van Els CA; van Eden W; Broere F
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14134-9. PubMed ID: 22891339
[TBL] [Abstract][Full Text] [Related]
16. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity.
Haque M; Song J; Fino K; Sandhu P; Song X; Lei F; Zheng S; Ni B; Fang D; Song J
Sci Rep; 2016 Feb; 6():20588. PubMed ID: 26846186
[TBL] [Abstract][Full Text] [Related]
17. Antigen-Specific Treg Therapy in Type 1 Diabetes - Challenges and Opportunities.
Serr I; Drost F; Schubert B; Daniel C
Front Immunol; 2021; 12():712870. PubMed ID: 34367177
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
[TBL] [Abstract][Full Text] [Related]
19. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
Terry LV; Oo YH
Front Immunol; 2020; 11():565518. PubMed ID: 33072105
[TBL] [Abstract][Full Text] [Related]
20. Human T regulatory cell therapy: take a billion or so and call me in the morning.
Riley JL; June CH; Blazar BR
Immunity; 2009 May; 30(5):656-65. PubMed ID: 19464988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
